Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

iTRAQ- and LC-MS/MS-based quantitative proteomics reveals Pqlc2 as a potential regulator of hepatic glucose metabolism and insulin signalling pathway during fasting.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0425076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1681 (Electronic) Linking ISSN: 03051870 NLM ISO Abbreviation: Clin Exp Pharmacol Physiol
    • بيانات النشر:
      Publication: Oxford, England : Wiley-Blackwell
      Original Publication: Oxford, Blackwell Scientific Publications.
    • الموضوع:
    • نبذة مختصرة :
      Glucose homeostasis is tightly controlled by balance between glucose production and uptake in liver tissue upon energy shortage condition. Altered glucose homeostasis contributes to the pathophysiology of metabolic disorders including diabetes and obesity. Here, we aimed to analyse the change of proteomic profile upon prolonged fasting in mice with isobaric tag for relative and absolute quantification (iTRAQ) labelling followed by liquid chromatography-mass spectrometry (LC/MS) technology. Adult male mice were fed or fasted for 16 hours and liver tissues were collected for iTRAQ labelling followed by LC/MS analysis. A total of 322 differentially expressed proteins were identified, including 189 upregulated and 133 downregulated proteins. Bioinformatics analyses, including Gene Ontology analysis (GO), Kyoto encyclopaedia of genes and genomes analysis (KEGG) and protein-protein interaction analysis (PPI) were conducted to understand biological process, cell component, and molecular function of the 322 differentially expressed proteins. Among 322 hepatic proteins differentially expressed between fasting and fed mice, we validated three upregulated proteins (Pqlc2, Ehhadh and Apoa4) and two downregulated proteins (Uba52 and Rpl37) by western-blotting analysis. In cultured HepG2 hepatocellular cells, we found that depletion of Pqlc2 by siRNA-mediated knockdown impaired the insulin-induced glucose uptake, inhibited GLUT2 mRNA level and suppressed the insulin-induced Akt phosphorylation. By contrast, knockdown of Pqlc2 did not affect the cAMP/dexamethasone-induced gluconeogenesis. In conclusion, our study provides important information on protein profile change during prolonged fasting with iTRAQ- and LC-MS/MS-based quantitative proteomics, and identifies Pqlc2 as a potential regulator of hepatic glucose metabolism and insulin signalling pathway in this process.
      (© 2020 John Wiley & Sons Australia, Ltd.)
    • References:
      Mulukutla BC, Yongky A, Le T, Mashek DG, Hu WS. Regulation of Glucose Metabolism - A Perspective From Cell Bioprocessing. Trends Biotechnol. 2016;34(8):638-651.
      Oosterveer MH, Schoonjans K. Hepatic glucose sensing and integrative pathways in the liver. Cell Mol Life Sci. 2014;71(8):1453-1467.
      Zhang X, Yang S, Chen J, Su Z. Unraveling the regulation of hepatic gluconeogenesis. Front Endocrinol (Lausanne). 2018;9:802.
      Wu H, Deng X, Shi Y, Su Y, Wei J, Duan H. PGC-1alpha, glucose metabolism and type 2 diabetes mellitus. J Endocrinol. 2016;229(3):R99-R115.
      Liu Y, Dentin R, Chen D, et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature. 2008;456(7219):269-273.
      Yoon JC, Puigserver P, Chen G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 2001;413(6852):131-138.
      Jiang W, Wang S, Xiao M, et al. Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol Cell. 2011;43(1):33-44.
      Wang Y, Li G, Goode J, et al. Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. Nature. 2012;485(7396):128-132.
      Takeuchi Y, Yahagi N, Aita Y, et al. KLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during Fasting. Cell Rep. 2016;16(9):2373-2386.
      Bantubungi K, Hannou SA, Caron-Houde S, et al. Cdkn2a/p16Ink4a regulates fasting-induced hepatic gluconeogenesis through the PKA-CREB-PGC1alpha pathway. Diabetes. 2014;63(10):3199-3209.
      Dentin R, Hedrick S, Xie J, Yates J 3rd, Montminy M. Hepatic glucose sensing via the CREB coactivator CRTC2. Science. 2008;319(5868):1402-1405.
      Herzig S, Long F, Jhala US, et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature. 2001;413(6852):179-183.
      Zhang CS, Hawley SA, Zong Y, et al. Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature. 2017;548(7665):112-116.
      Javary J, Allain-Courtois N, Saucisse N, et al. Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling. Gut. 2018;67(12):2192-2203.
      Sun Z, Miller RA, Patel RT, et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med. 2012;18(6):934-942.
      Liang Q, Zhong L, Zhang J, et al. FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting. Diabetes. 2014;63(12):4064-4075.
      Park BY, Jeon JH, Go Y, et al. PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels. Diabetes. 2018;67(10):2054-2068.
      Shishova EY, Stoll JM, Ersoy BA, et al. Genetic ablation or chemical inhibition of phosphatidylcholine transfer protein attenuates diet-induced hepatic glucose production. Hepatology. 2011;54(2):664-674.
      Krisko TI, LeClair KB, Cohen DE. Genetic ablation of phosphatidylcholine transfer protein/StarD2 in ob/ob mice improves glucose tolerance without increasing energy expenditure. Metabolism. 2017;68:145-149.
      Nesteruk M, Hennig EE, Mikula M, et al. Mitochondrial-related proteomic changes during obesity and fasting in mice are greater in the liver than skeletal muscles. Funct Integr Genomics. 2014;14(1):245-259.
      Adeva-Andany MM, Pérez-Felpete N, Fernández-Fernández C, Donapetry-García C, Pazos-García C. Liver glucose metabolism in humans. Biosci Rep. 2016;36(6):e00416.
      Liu J, Liu Z, Chen L, Zhang H. iTRAQ-based proteomic analysis reveals alterations in the liver induced by restricted meal frequency in a pig model. Nutrition. 2016;32(7-8):871-876.
      Wang W, Palmfeldt J, Mohsen AW, Gregersen N, Vockley J. Fasting induces prominent proteomic changes in liver in very long chain Acyl-CoA dehydrogenase deficient mice. Biochem Biophys Rep. 2016;8:333-339.
      Chen Y, Wu Y, Yang Y, et al. Transcriptomic and proteomic analysis of potential therapeutic target genes in the liver of metformintreated SpragueDawley rats with type 2 diabetes mellitus. Int J Mol Med. 2018;41(6):3327-3341.
      Senthivinayagam S, McIntosh AL, Moon KC, Atshaves BP. Plin2 inhibits cellular glucose uptake through interactions with SNAP23, a SNARE complex protein. PLoS One. 2013;8(9):e73696.
      Park PJ, Kong SW, Tebaldi T, Lai WR, Kasif S, Kohane IS. Integration of heterogeneous expression data sets extends the role of the retinol pathway in diabetes and insulin resistance. Bioinformatics. 2009;25(23):3121-3127.
      Jezegou A, Llinares E, Anne C, et al. Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy. Proc Natl Acad Sci U S A. 2012;109(50):E3434-E3443.
      Llinares E, Barry AO, Andre B. The AP-3 adaptor complex mediates sorting of yeast and mammalian PQ-loop-family basic amino acid transporters to the vacuolar/lysosomal membrane. Sci Rep. 2015;5:16665.
      Jeung YJ, Lee K, Lee HJ, et al. Cationic amino acid transporter PQLC2 is a potential therapeutic target in gastric cancer. Cancer Sci. 2019;110(4):1453-1463.
      Feng L, Frommer WB. Structure and function of SemiSWEET and SWEET sugar transporters. Trends Biochem Sci. 2015;40(8):480-486.
      Xu Y, Tao Y, Cheung LS, et al. Structures of bacterial homologues of SWEET transporters in two distinct conformations. Nature. 2014;515(7527):448-452.
      Saudek V. Cystinosin, MPDU1, SWEETs and KDELR belong to a well-defined protein family with putative function of cargo receptors involved in vesicle trafficking. PLoS One. 2012;7(2):e30876.
      Amick J, Tharkeshwar AK, Talaia G, Ferguson SM. PQLC2 recruits the C9orf72 complex to lysosomes in response to cationic amino acid starvation. J Cell Biol. 2020;219(1):e201906076.
      Houten SM, Denis S, Argmann CA, et al. Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids. J Lipid Res. 2012;53(7):1296-1303.
      Zhao S, Xu W, Jiang W, et al. Regulation of cellular metabolism by protein lysine acetylation. Science. 2010;327(5968):1000-1004.
      Desert C, Duclos MJ, Blavy P, et al. Transcriptome profiling of the feeding-to-fasting transition in chicken liver. BMC Genom. 2008;9:611.
      Harney DJ, Hutchison AT, Hatchwell L, et al. Proteomic analysis of human plasma during intermittent fasting. J Proteome Res. 2019;18(5):2228-2240.
      VerHague MA, Cheng D, Weinberg RB, Shelness GS. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler Thromb Vasc Biol. 2013;33(11):2501-2508.
      Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40(2):161-169.
      Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 2003;423(6939):550-555.
      Lu M, Wan M, Leavens KF, et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med. 2012;18(3):388-395.
      Wang L, Scott I, Zhu L, et al. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis. Nat Commun. 2017;8(1):523.
      Liu Y, Wang T, Ji YJ, et al. A C9orf72-CARM1 axis regulates lipid metabolism under glucose starvation-induced nutrient stress. Genes Dev. 2018;32(21-22):1380-1397.
      Choi H, Koh HWL, Zhou L, et al. Plasma Protein and MicroRNA Biomarkers of Insulin Resistance: A Network-Based Integrative -Omics Analysis. Front Physiol. 2019;10:379.
      Xu J, Gao H, Zhang L, et al. Melatonin alleviates cognition impairment by antagonizing brain insulin resistance in aged rats fed a high-fat diet. J Pineal Res. 2019;67(2):e12584.
      Jayabalan N, Lai A, Nair S, et al. Quantitative Proteomics by SWATH-MS Suggest an Association Between Circulating Exosomes and Maternal Metabolic Changes in Gestational Diabetes Mellitus. Proteomics. 2019;19(1-2):e1800164.
      Srisawat K, Shepherd SO, Lisboa PJ, Burniston JG. A Systematic Review and Meta-Analysis of Proteomics Literature on the Response of Human Skeletal Muscle to Obesity/Type 2 Diabetes Mellitus (T2DM) Versus Exercise Training. Proteomes. 2017;5(4):30.
      Manousopoulou A, Al-Daghri NM, Sabico S, et al. Polycystic ovary syndrome and insulin physiology: an observational quantitative serum proteomics study in adolescent, normal-weight females. Proteomics Clin Appl. 2019;13(5):e1800184.
      Zeidan B, Manousopoulou A, Garay-Baquero DJ, et al. Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study. Breast Cancer Res. 2018;20(1):19.
      Chen L, Huang Y, Xu M, Cheng Z, Zhang D, Zheng J. iTRAQ-Based Quantitative Proteomics Analysis of Black Rice Grain Development Reveals Metabolic Pathways Associated with Anthocyanin Biosynthesis. PLoS One. 2016;11(7):e0159238.
      Li DJ, Li YH, Yuan HB, Qu LF, Wang P. The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia. Metabolism. 2017;68:31-42.
      Mercau ME, Calanni JS, Aranda ML, et al. Melatonin prevents early pituitary dysfunction induced by sucrose-rich diets. J Pineal Res. 2019;66(2):e12545.
      Li DJ, Liu J, Hua X, et al. Nicotinic acetylcholine receptor alpha7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease. Metabolism. 2018;79:52-63.
      Li DJ, Tong J, Zeng FY, et al. Nicotinic ACh receptor alpha7 inhibits PDGF-induced migration of vascular smooth muscle cells by activating mitochondrial deacetylase sirtuin 3. Br J Pharmacol. 2019;176(22):4388-4401.
      Park JH, Seo I, Shim HM, Cho H. Melatonin ameliorates SGLT2 inhibitor-induced diabetic ketoacidosis by inhibiting lipolysis and hepatic ketogenesis in type 2 diabetic mice. J Pineal Res. 2020;68(2):e12623.
      Li DJ, Tong J, Li YH, et al. Melatonin safeguards against fatty liver by antagonizing TRAFs-mediated ASK1 deubiquitination and stabilization in a beta-arrestin-1 dependent manner. J Pineal Res. 2019;67(4):e12611.
      Huang CC, Chiou CH, Liu SC, et al. Melatonin attenuates TNF-alpha and IL-1beta expression in synovial fibroblasts and diminishes cartilage degradation: Implications for the treatment of rheumatoid arthritis. J Pineal Res. 2019;66(3):e12560.
    • Contributed Indexing:
      Keywords: Pqlc2; fasting; gluconeogenesis; iTRAQ technology; insulin; liver; proteomics
    • الرقم المعرف:
      IY9XDZ35W2 (Glucose)
      0 (Insulin)
    • الموضوع:
      Date Created: 20201014 Date Completed: 20240724 Latest Revision: 20240725
    • الموضوع:
      20260130
    • الرقم المعرف:
      10.1111/1440-1681.13419
    • الرقم المعرف:
      33051888